BIRD - Belgian Inflammatory Bowel Disease Research and Development

Postgraduaat IMID- verpleegkundige Wist je dat het aantal patiënten met Immune Mediated Inflammatory Diseases (IMID), waaronder vb. reumatoïde artritis, psoriasis en de ziekte van Crohn, wereldwijd blijft stijgen? 🤔🏥 Daarom is de postgraduaat opleiding 'IMID Nurse' bij PXL-NeXT essentieel voor élke verpleegkundige die zich wil specialiseren in deze groeiende zorgbehoefte, ongeacht de discipline. Deze opleiding biedt een unieke combinatie van theorie, praktijk en casuïstiek, ondersteund door wetenschappelijk onderzoek en bereidt je voor op verschillende rollen. Je leert alles over... 👉 De pathofysiologie van IMID 👉 Patiëntbegeleiding 👉 De nieuwste behandelingsmethoden 👉 Manieren om efficiënt multidisciplinair samen te werken De samenwerking met experts uit verschillende vakgebieden garandeert bovendien een compleet en praktijkgericht leertraject. Ontdek alles over de opleiding via de link hieronder! 👇 📅 Startdatum: 7 oktober 2024 🔗 https://lnkd.in/d7wqXYHG Hogeschool PXL BIRD - Belgian Inflammatory Bowel Disease Research and Development BINAstoria Rheuma.be Professional (KBVR- SRBR) BDNA BeHPR Thanny Bries Elfie Deprez

We currently have 140 registrations for the BIRD Congress in November! Will you be the next to be added to the list... or do you still need to be convinced? Watch this short clip to hear why you shouldn't miss it! 👀

☀️ We are pleased to bring you the 2024 edition of our BIRD summer newsletter. Take a moment to get caught up on the latest updates of all of our BIRD activities! In addition, we welcome you all at the BIRD 2024 Third Annual Congress: Join us and register at https://lnkd.in/gcMYDUda.

📢 📢 Each month, EduCom, the educational committee of BIRD, selects a research paper of the month for you to read on our website. The selected paper for July is "Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study" (Lancet Gastroenterol Hepatol. 2024 June vol 9, issue 6, p521-538). Take some time this week to read this month's selected paper here: https://lnkd.in/eRySgpsG

Curious to know what the BIRD Congress is all about? 👀Hear it first-hand from our members! And then visit https://lnkd.in/epJ92bVc to get yourself registered! You won't want to miss it!

Huge congratulations to our two KU Leuven Master students, who successfully defended their Master's theses on Friday! 🎉🎉 Axelle Raeves and Jolien Dierickx, it was a great pleasure to work with you and we wish you the best in your future endeavors. We are happy to play a part in the growth of young scientists in the field of IBD and eagerly await our next master student Leonie Govaerts in September!

We recently passed the 1000 followers mark here on LinkedIn! 🎉 Thank you for interacting with and sharing our posts – this allows us to reach a wider audience and continue to grow! We use this tool to share the latest BIRD updates and activities and have found it to be an ideal way to reach our IBD community. In addition to the growth of our followers (⬆️71% in 18 months), we are proud to see an increase in membership from both our physicians and allied health professionals. Thank you for the support and interest in our organization, it encourages us to continue to work towards our aim of improving the quality of care for patients with IBD.  ☺️

🌟 Exciting News! 🌟   We are thrilled to announce that the POMEROL trial has recently been approved in Belgium! 🎉 This international clinical trial, sponsored by GETAID, is an important step forward in evaluating the advantage of treatment escalation for Crohn's disease patients experiencing moderate endoscopic recurrence post-surgery.   The POMEROL trial is already ongoing in France and has recently expanded to Belgium (with 15 participating sites), Spain, and Australia. We are currently activating all Belgian sites and are looking forward to continue our collaboration with GETAID, all participating sites and involved partners to advance this crucial research.   (EU CT number 2023-508242-18-00)   Stay tuned for more updates as we move forward with this study.

Registrations are rolling in for our 3rd Annual BIRD Congress! 🎉 Will you be the next to join our list of attendees? See the program and register at http://bird-congress.be